title: Drug development for progeria yields insights into normal aging.
authors: Kevin
authors: K
authors: Jiang
mesh_terms: D000375:Aging; D002648:Child; D002986:Clinical Trials as Topic; D004164:Diphosphonates / Q000627:therapeutic use; D055808:Drug Discovery; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D034904:Lamin Type A / Q000235:genetics; D009154:Mutation; D010880:Piperidines / Q000627:therapeutic use; D017035:Pravastatin / Q000627:therapeutic use; D011371:Progeria / Q000188:drug therapy* / Q000235:genetics; D011725:Pyridines / Q000627:therapeutic use; D013997:Time Factors; D000077211:Zoledronic Acid; D003986:Dibenzocycloheptenes
chemical_list: D004164:Diphosphonates; D007093:Imidazoles; D034904:Lamin Type A; D010880:Piperidines; D017035:Pravastatin; D011725:Pyridines; D000077211:Zoledronic Acid; C115354:lonafarnib; D003986:Dibenzocycloheptenes
references: Nature. 2003 May 15;423(6937):293-8
references: 12714972
references: Sci Transl Med. 2011 Jun 29;3(89):89ra58
references: 21715679
references: Science. 2006 May 19;312(5776):1059-63
references: 16645051
references: Cell Metab. 2012 Dec 5;16(6):738-50
references: 23217256
references: Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):16666-71
references: 23012407